Amoun, Valeant Pharmaceuticals deal

Valeant will acquire Amoun for $800 million. Amoun markets antihypertensives, broad-spectrum antibiotics and antidiarrheals. Valeant plans to use the acquisition to expand into the Middle East and Nor...